Amarin Corp Plc (AMRN)

[couldbebetter]

jasbg, A battle it is. One would hope this is fought on several "fronts."

1. Legal...Do whatever it takes to keep generics off the market.
(Maybe some unconventional warfare strategy here?) If it were up
to me I'd sue whoever would launch on patent infringement grounds
whether it was a solid case or not...including appeals. When the
"System" is unfair, that is the time to play unfair.

2. Pricing, if need be cut prices on an authorized generic just so
generics will not stay in business for long. (Of course, this game
is best played by a BP acquirer of AMRN that would use their financial
clout to lock up feed stock, in part to be a low cost provider of
Vascepa in Europe and other protected territories, and if needed
to undercut generics in pricing.

3. Political...Get the FDA on AMRN's side. Go to the medical authorities
to figure out a reasonable solution. For example: Offer a pricing
agreement for Medicare/Medicaid to circumvent generics (if such a
thing is even feasible) In other words management must be creative
in finding solutions.